Day: November 10, 2022

Todos Medical Terminates Tollovid™ Products License & Distribution Agreement with T-Cell Protect Hellas S.A.

Written by Customer Service on November 10, 2022. Posted in Public Companies.

New York, NY, and Tel Aviv, ISRAEL, Nov. 10, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that it has terminated the Tollovid™ products license and distribution agreement it had with T-Cell Protect Hellas S.A. T-Cell Protect has acknowledged the termination and has agreed to remove Todos Medical’s name and logo from its marketing materials, and will remove any reference to Dr. Dorit Arad’s work being associated with T-Cell Protect Hellas S.A. products. To learn more about the 3CL protease in SARS-CoV-2 replication, please visit www.3clpro.com. To purchase Tollovid please visit Amazon or www.MyTollovid.com. About Todos Medical Ltd.Founded in Rehovot, Israel with offices in New York City, Todos Medical...

Muscle Maker, Inc. Posts Q3 and year-to-date 2022 Results

Written by Customer Service on November 10, 2022. Posted in Public Companies.

Growth Continues With Seven New Pokemoto Locations Opened, Operating Results Improve Year-Over–Year While Company Maintains Strong Cash Position Fort Worth, Texas, Nov. 10, 2022 (GLOBE NEWSWIRE) — Muscle Maker, Inc. (Nasdaq: GRIL), the parent company of Muscle Maker Grill restaurants, Pokemoto Hawaiian Poke and SuperFit Foods meal prep, today announced the posting of its third quarter 2022 financial results on November 10th for the three- and nine-months ending September 30, 2022. Michael Roper, CEO of Muscle Maker, Inc., commented, “The recently posted year-to-date 2022 financial results compared to 2021 show a continued improvement in our operating metrics and profits as we focus on optimizing the Muscle Maker Grill brand and expanding Pokemoto. Our year-to-date operating profits, as a percentage of total revenue, improved...

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Children 5 Through 11 Years of Age in European Union

Written by Customer Service on November 10, 2022. Posted in Public Companies.

NEW YORK and MAINZ, GERMANY, November 10, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY® Original/Omicron BA.4/BA.5 5/5-µg) has been recommended for marketing authorization by the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) for children 5 through 11 years of age. The European Commission will review the CHMP recommendation and is expected to make a final decision soon. The Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine is currently authorized in the European Union (EU) as a booster dose for individuals aged 12 years and older. Today’s CHMP recommendation to include children 5 through 11 years of age was based on safety and immunogenicity data from the companies’ Omicron BA.1-adapted...

Dimensional Fund Advisors Ltd. : Form 8.3 – APPRECIATE GROUP PLC – Ordinary Shares

Written by Customer Service on November 10, 2022. Posted in Mergers And Acquisitions.

** AMENDMENT**This form replaces the filing reported on 7 November 2022 10:42am. Amendments were made to sections 1(c), 1(f), 2(a) and 3(a) FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: Dimensional Fund Advisors Ltd. (“Dimensional”), in its capacity as investment manager and on behalf its affiliates who are also investment managers. Dimensional and its affiliates expressly disclaim beneficial ownership of the shares described in this form 8.3(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries...

Asante Announces Commercial Production at the Bibiani Gold Mine

Written by Customer Service on November 10, 2022. Posted in Public Companies.

VANCOUVER, British Columbia, Nov. 10, 2022 (GLOBE NEWSWIRE) — Asante Gold Corporation (CSE:ASE | GSE:ASG | FRANKFURT:1A9 | U.S.OTC:ASGOF) is pleased to announce that the Bibiani Gold Mine (“Bibiani”) ramp up remains on track and commercial production has been established with three months of consistent production since the first gold pour was completed in early July 2022. Operational highlights include:The first gold pour at Bibiani was completed July 7, 2022, two months ahead of schedule. Metallurgical performance and gold production is on track with the ramp up schedule.All process plant and mine facilities have been operating on a 24 hour per day basis from late June, with ~220,000 tonnes in September and~206,000 tonnes in October. Asante plans to increase throughput to 250,000 tonnes ore per month by Q1 2023.Gold production...

Credent Wealth Management Merges Record Three Firms in 2022

Written by Customer Service on November 10, 2022. Posted in Mergers And Acquisitions.

Credent’s Integrator Model Maximizes Advisors’ Wealth with Equity Partnerships AUBURN, Ind., Nov. 10, 2022 (GLOBE NEWSWIRE) — Credent Wealth Management is pleased to announce Dan Steichen (Personal Wealth Partners), Brad Michels (Financial Architects), and Steve Swicegood (Conscious Money Solutions) as the latest partners to join Credent Wealth. Through these partnerships, Credent expands its locations to River Falls, Wisconsin; Minneapolis, Minnesota; Louisville, Kentucky; and Amarillo, Texas. Under their integrator model, Credent’s flexible options allow advisors to remain involved and advance their personal and professional success through equity rollovers and Credent’s structured growth initiatives. For a limited time, Credent is offering similar Founder’s share partnerships, giving advisors a secure succession plan for their...

Israeli Cannabis Technology Company BYND Cannasoft Enterprises Inc. Announces Third Quarter 2022 Financial Results

Written by Customer Service on November 10, 2022. Posted in Earnings Releases And Operating Results.

Company reports 494% growth in 2022 assets to $33 million USD and strengthened balance sheet while increasing gross margins and reducing losses VANCOUVER, British Columbia, Nov. 10, 2022 (GLOBE NEWSWIRE) — BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN, CSE: BYND) (“BYND” or the “Company”), has released its financial results for the nine-month period ended September 30, 2022. Full versions of BYND’s unaudited consolidated interim financial statements and management discussion and analysis for the period, can be found on www.sedar.com. Q3 2022 Financial Highlights:Revenue increased 10% to $227,954 for the three-month period ended September 30, 2022 from $207,653 for the previous quarter Gross Profit increased to 58% for the nine-month period ended September 30, 2022 from 49% for the same period in 2021. Net loss decreased 79%...

3D Cell Culture Market to Offer Revenue Opportunity of $14.63 Billion by 2028 | Personalized Medicine To Boost Market Growth

Written by Customer Service on November 10, 2022. Posted in Mergers And Acquisitions.

Global 3D cell culture market was valued at USD 3.83 Billion in 2021, and it is expected to reach a value of USD 14.63 Billion by 2028, at a CAGR of 21.12% over the forecast period (2022–2028). Westford, USA, Nov. 10, 2022 (GLOBE NEWSWIRE) — As the world progresses, so does the demand for more efficient and innovated technologies. One such technology on the rise is 3D cell culture. 3D cell culture is a process in which cells are grown in an artificial three-dimensional environment that more accurately reflects their natural conditions. This type of culture has many benefits over traditional two-dimensional cell cultures in the global 3D cell culture market, including improved cellular functions, better model reproducibility, and reduced animal testing. The growing demand for 3D cell culture market can be attributed to its many...

Constellation Brands Announces Completion of Previously Announced Elimination of Class B Common Stock

Written by Customer Service on November 10, 2022. Posted in Dividend Reports And Estimates.

VICTOR, N.Y., Nov. 10, 2022 (GLOBE NEWSWIRE) — Constellation Brands (NYSE: STZ), a leading beverage alcohol company, announced today that it completed the previously announced reclassification transaction and eliminated its Class B Common Stock. Trading in the Class B Common Stock will cease after the markets close today, at which time Constellation’s publicly listed stock will consist solely of Class A Common Stock. In connection with completing the transaction, the company has deposited for distribution the $64.64 per share cash consideration, or approximately $1.5 billion in aggregate, to holders of Class B Common Stock. Financing for the cash payment was provided through funding of the previously announced delayed draw term loan credit agreement and Constellation’s existing commercial paper program. The interest expense associated...

Edible Garden Reports Second Consecutive Quarter of Year-Over-Year Revenue Growth; Revenue Increases 12.5% Year-Over-Year for the Third Quarter of 2022

Written by Customer Service on November 10, 2022. Posted in Earnings Releases And Operating Results.

Edible Garden’s Heartland Facility – Q3 Acquisition Expected to Begin Operations by Year-End Expanding Capacity to Support up to $20 Million in Annualized Revenue Conference Call to Be Held Today at 11:00 am ET BELVIDERE, N.J., Nov. 10, 2022 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic, and sustainable produce, today provided a business update and reported financial results for the three- and nine-month periods ended September 30, 2022. Mr. Jim Kras, Chief Executive Officer of Edible Garden, commented, “We continue to generate solid year-over-year revenue growth, and believe we can accelerate that growth through the execution of our business strategy and prudent deployment of capital...

Day: November 10, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice